| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |